| Literature DB >> 28011486 |
I-Tsang Chiang1,2,3, Wei-Ting Chen4, Chih-Wei Tseng5, Yen-Chung Chen2,6, Yu-Cheng Kuo7, Bi-Jhih Chen8, Mao-Chi Weng9, Hwai-Jeng Lin10,11, Wei-Shu Wang12,13,14.
Abstract
The aim of the present study was to investigate the antitumor effect and mechanism of action of hyperforin in hepatocellular carcinoma (HCC) SK-Hep1 cells in vitro. Cells were treated with different concentrations of hyperforin for different periods of time. Effects of hyperforin on cell viability, apoptosis signaling, and expression of anti-apoptotic and proliferative proteins [cellular FLICE-like inhibitory protein (c-FLIP), X-linked inhibitor of apoptosis protein (XIAP), myeloid cell leukemia 1(MCL1), and cyclin-D1] were investigated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, flow cytometry, and western blotting. Hyperforin significantly inhibited cell viability and expression of anti-apoptotic and proliferative proteins. We also found that hyperforin significantly induced accumulation of cells in sub-G1 phase, loss of mitochondrial membrane potential, and increased levels of active caspase-3, and caspase-8. Taken together, our findings indicate that hyperforin triggers inhibition of tumor cell growth by inducing intrinsic and extrinsic apoptotic pathways in HCC SK-Hep1 cells. CopyrightEntities:
Keywords: Hepatocellular carcinoma; apoptosis; hyperforin
Mesh:
Substances:
Year: 2017 PMID: 28011486 DOI: 10.21873/anticanres.11301
Source DB: PubMed Journal: Anticancer Res ISSN: 0250-7005 Impact factor: 2.480